Dementia Management With Interactive Technology
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03916588 |
Recruitment Status :
Enrolling by invitation
First Posted : April 16, 2019
Last Update Posted : March 10, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Dementia Memory Disorders in Old Age | Behavioral: Individualized Care Plan |
Study Type : | Observational |
Estimated Enrollment : | 56 participants |
Observational Model: | Ecologic or Community |
Time Perspective: | Prospective |
Official Title: | Dementia Management With Interactive Technology |
Actual Study Start Date : | August 16, 2018 |
Estimated Primary Completion Date : | December 31, 2020 |
Estimated Study Completion Date : | December 31, 2020 |

Group/Cohort | Intervention/treatment |
---|---|
Memory Care Unit Residents
Residents on a locked memory care unit in southeastern Louisiana will be enrolled. Engaged family members and staff will also consent to provide qualitative information on the resident.
|
Behavioral: Individualized Care Plan
Medical, neuropsychological, and social assessment of patient's cognitive, behavioral, medical, and environmental needs with a focus on improving quality of life, reducing health care utilization, and improving staff/family caregiving burden along with a specific plan to address and monitor identified patient and staff/facility needs |
- Mortality/Survival Rate [ Time Frame: through study completion, an average of 1 year ]
- Quality of Life Scale (QoL) [ Time Frame: through study completion, an average of 1 year ]Neuropsychiatric/behavioral symptoms
- Fall Incidence [ Time Frame: through study completion, an average of 1 year ]Neuropsychiatric/behavioral symptoms
- Zarit Caregiver Burden [ Time Frame: through study completion, an average of 1 year ]Family burden
- Patient Care Team Burden Scale (PCTB) [ Time Frame: through study completion, an average of 1 year ]staff caregiver burden
- Healthcare Utilization [ Time Frame: through study completion, an average of 1 year ]Number of visits to hospital or clinic
- Fitbit Charge HR activity and sleep data [ Time Frame: through study completion, an average of 1 year ]Average daily steps, minutes asleep

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Residents living in a specific locked memory care unit in Southeastern Louisiana or
- Family or staff identified as part of the care team of the resident

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03916588
United States, Louisiana | |
Ochsner Health System | |
New Orleans, Louisiana, United States, 70121 |
Principal Investigator: | R. John Sawyer, PhD | Ochsner Health System |
Responsible Party: | Ochsner Health System |
ClinicalTrials.gov Identifier: | NCT03916588 |
Other Study ID Numbers: |
2018.078 |
First Posted: | April 16, 2019 Key Record Dates |
Last Update Posted: | March 10, 2020 |
Last Verified: | March 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Dementia Memory Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Neurocognitive Disorders Mental Disorders Neurobehavioral Manifestations Neurologic Manifestations |